Discontinued — last reported Q3 '23
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Refined Products and Crude Oil | $967.00M | $958.00M | $1.03B | $1.03B | $1.01B | $1.27B | $1.26B | $1.18B |
| Natural Gas Pipelines | — | — | $764.00M | $811.00M | $843.00M | $860.00M | $929.00M | $1.04B |
| Natural Gas Liquids | $418.00M | $417.00M | $484.00M | $524.00M | $550.00M | $597.00M | $652.00M | $718.00M |
| Natural Gas Gathering and Processing | $30.00M | $31.00M | $33.00M | $37.00M | $39.00M | $40.00M | $40.00M | $40.00M |
| Total | — | — | — | — | — | — | — | — |